Abstract
Leptin (LPT) is associated with a number of cardiovascular risk factors, such as high blood pressure (BP), insulin resistance and excess in body weight. Some studies find an unfavorable cross-sectional association between LPT and renal disease, in particular in patients with already known kidney dysfunction. There are few data on the relationship between LPT and changes in renal function over time in subjects without evidence of kidney dysfunction. Hence, the aim of this study is to estimate the predictive role of LPT on the decline in renal function occurring in an 8-year follow-up observation of a sample of adult apparently healthy men (The Olivetti Heart Study). The study includes 319 untreated normotensive and nondiabetic men without clinical evidence of renal dysfunction (creatinine clearance-CrCl > 60 mL/min/1.73 m2) at baseline. At baseline, LPT is significantly and positively associated with BMI, abdominal circumference, BP and Homa index, no relationship is found with CrCl. At the end of the 8-year follow-up, a significant association is detected between baseline LPT and changes occurring in BP. Moreover, an inverse correlation with changes in CrCl is found (r = − 0.12). This unfavorable relationship between baseline LPT and decline in renal function is also confirmed in the multivariate analyses, after adjustment for all potential confounders (R2 = 0.42, p < 0.01). The results of this prospective investigation suggest a predictive role of circulating LPT levels on decline in renal function over time, independently of main potential confounders, in normotensive and nondiabetic men with normal renal function at baseline.
![](https://cdn.statically.io/img/media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11739-018-1924-9/MediaObjects/11739_2018_1924_Fig1_HTML.png)
Similar content being viewed by others
References
Coresh J, Selvin E, Stevens LA et al (2007) Prevalence of chronic kidney disease in the United States. JAMA 7(17):2038–2047
Mancia G, Fagard R, Narkiewicz K et al (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 31:1281–1357
Loffreda S, Yang SQ, Lin HZ et al (1998) Leptin regulates proinflammatory immune responses. FASEB J. 12:57–65
Considine RV, Sinha MK, Heiman ML et al (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334(5):292–295
Galletti F, D’Elia L, Barba G et al (2008) High-circulating leptin levels are associated with greater risk of hypertension in men independently of body mass and insulin resistance: results of an eight-year follow-up study. J Clin Endocrinol Metab 93(10):3922–3926
Galletti F, Barbato A, Versiero M et al (2007) Circulating leptin levels predict the development of metabolic syndrome in middle-aged men: an 8-year follow-up study. J Hypertens 25(8):1671–1677
Galletti F, D’Elia L, De Palma D et al (2012) Hyperleptinemia is associated with hypertension, systemic inflammation and insulin resistance in overweight but not in normal weight men. Nutr Metab Cardiovasc Dis 22(3):300–306
Pecoits-Filho R, Nordfors L, Heimbürger O et al (2002) Soluble leptin receptors and serum leptin in end-stage renal disease: relationship with inflammation and body composition. Eur J Clin Invest 32(11):811–817
Barlovic DP, Zaletel J, Prezelj J (2009) Adipocytokines are associated with renal function in patients with normal range glomerular filtration rate and type 2 diabetes. Cytokine 46(1):142–145
Ambarkar M, Pemmaraju SV, Gouroju S et al (2016) Adipokines and their relation to endothelial dysfunction in patients with chronic kidney disease. J Clin Diagn Res 10(1):BC04
Ding N, Liu B, Song J et al (2016) Leptin promotes endothelial dysfunction in chronic kidney disease through AKT/GSK3β and β-catenin signals. Biochem Biophys Res Commun 480(4):544–551
Pedone C, Roshanravan B, Scarlata S, Patel KV, Ferrucci L, Incalzi RA (2015) Longitudinal association between serum leptin concentration and glomerular filtration rate in humans. PLoS One 10(2):e0117828
Strazzullo P, Barba G, Cappuccio FP et al (2001) Altered renal sodium handling in men with abdominal adiposity: a link to hypertension. J Hypertens 19(12):2157–2164
Iacone R, Russo O, Russo P et al (2002) Plasma leptin measurements in epidemiological investigation: comparison of two commonly used assays and estimate of regression dilution bias. Nutr Metab Cardiovasc Dis 12(2):71–79
Cappuccio FP, Strazzullo P, Farinaro E, Trevisan M (1993) Uric acid metabolism and tubular sodium handling. Results from a population-based study. JAMA 270(3):354–359
Sharma K, Considine RV, Beckie M et al (1997) Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Int 51:1980–1985
Kokot F, Adamczak M, Wiecek A (1998) Plasma leptin concentration in kidney transplant patients at the early post-transplant period. Nephrol Dial Transpl 13:2276–2280
Gomart S, Gaudreau-MeÂnard C, Jespers P et al (2017) Leptin-induced endothelium-independent vasoconstriction in thoracic aorta and pulmonary artery of spontaneously hypertensive rats: role of calcium channels and stores. PLoS One 12(1):e0169205
Lam QL, Lu L (2007) Role of leptin in immunity. Cell Mol Immunol 4:1–13
Albert CM, Ma J, Rifai N, Stampfer MJ, Ridker PM (2002) Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation 105:2595–2599
Ridker PM, Rifai N, Rose L, Buring JE, Cook NR (2002) Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347:1557–1565
Martin SS, Qasim A, Reilly MP (2008) Leptin resistance a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J Am Coll Cardiol 52:1201–1210
Singh P, Hoffmann M, Wolk R, Shamsuzzaman AS, Somers VK (2007) Leptin induces C-reactive protein expression in vascular endothelial cells. Arterioscler Thromb Vasc Biol 27:e302–e307
Santos-Alvarez J, Goberna R, Sanchez-Margalet V (1999) Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol 194:6–11
Grunfeld C, Zhao C, Fuller J et al (1996) Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest 97:2152–2157
Baumann H, Morella KK, White DW et al (1996) The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc Natl Acad Sci USA 93:8374–8378
Wilson CA, Bekele G, Nicolson M, Ravussin E, Pratley RE (1997) Relationship of the white blood cell count to body fat: role of leptin. Br J Haematol 99:447–451
Mabuchi T, Yatsuya H, Tamakoshi K et al (2005) Association between serum leptin concentration and white blood cell count in middle-aged Japanese men and women. Diabetes Metab Res Rev 21:441–447
Ortega E, Gilabert R, Nunez I, Cofan M, Sala- Vila A, de Groot E, Ros E (2012) White blood cell count is associated with carotid and femoral atherosclerosis. Atherosclerosis 221:275–281
Laharrague P, Oppert JM, Brousset P et al (2000) High concentration of leptin stimulates myeloid differentiation from human bone marrow CD34 + progenitors: potential involvement in leukocytosis of obese subjects. Int J Obes Relat Metab Disord 24:1212–1216
Yamagishi SI, Edelstein D, Du XL, Kaneda Y, Guzman M, Brownlee M (2001) Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 276:25096–25100
O’Rourke L, Gronning LM, Yeaman SJ, Shepherd PR (2002) Glucose dependent regulation of cholesterol ester metabolism in macrophages by insulin and leptin. J Biol Chem 277:42557–42562
Shamsuzzaman AS, Winnicki M, Wolk R et al (2004) Independent association between plasma leptin and C-reactive protein in healthy humans. Circulation 109:2181–2185
Acknowledgements
Conception and design: LD, FG. Analysis and interpretation of the data: LD, MM, LP, FG. Drafting of the article: LD, MM, LP, PS, FG. Critical revision of the article for important intellectual content: LD, RI, OR, PS, FG. Final approval of the article: all Authors. Statistical expertise: LD, FG. Administrative, technical, or logistic support: RI, OR, PS, FG. Collection and assembly of data: LD, RI, OR.
Funding
The study was not supported by external funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflict of interest.
Statements on human and animal rights
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The local Ethics Committee (The Ethics Committee-Federico II University of Naples) approved the Olivetti study protocol.
Informed consent
Written informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
D’Elia, L., Manfredi, M., Perna, L. et al. Circulating leptin levels predict the decline in renal function with age in a sample of adult men (The Olivetti Heart Study). Intern Emerg Med 14, 507–513 (2019). https://doi.org/10.1007/s11739-018-1924-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-018-1924-9